Answers are grounded in this paper and cite their sources.
While there is considerable interest in legumes as a food source, there are no validated biomarkers for green beans ( Phaseolus vulgaris , L.) intake. The objective of the current work is to identify and assess the dose–response of food intake biomarkers of green beans. In an acute intervention study, 27 participants consumed green beans in the study center and urine samples were collected pre‐ and post‐consumption. Metabolites were measured by nuclear magnetic resonance ( 1 H‐NMR) and liquid chromatography–mass spectrometry (LC–MS). Statistical analysis determined features that changed post‐consumption of green beans. Selected metabolites were assessed for dose–response in a follow‐up study ( n = 16). Analysis revealed 745 1 H‐NMR spectral regions and 318 LC–MS features that increased in intensity over time following consumption of green beans. Three 1 H‐NMR and 12 LC–MS metabolites displayed a dose–response relationship to increasing portion size of green beans ( p <0.05), including amino acid conjugates (glycine conjugate, N‐phenylacetylglutamine), hydroxyabscisic acid glucuronide and amino‐hydroxybenzoic acid. Partial least squares discriminant analysis predicted low or high green bean intake with 91.6% accuracy. We identified 15 urinary food intake biomarkers of green beans. A biomarker panel classified individuals as low or high green bean consumers with good accuracy, progressing ongoing efforts to improve dietary assessment methods.
No takes yet. Share an insight, caveat, or question.
Finlay et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: